Gansu Wuwei Heavy Ion Center - Carbon Ion Cancer Treatment

Carbon‑ion radiotherapy is internationally recognized as a cutting‑edge cancer treatment technology. The Heavy Ion Center of Gansu Wuwei Cancer Hospital is the clinical application site for China's first and second carbon‑ion therapy systems with independent intellectual property rights. Since its clinical launch in March 2020, the center has accumulated extensive experience in heavy ion facility development, clinical application, and operational management, with over 3,200 patients treated to date. In terms of clinical application, technological development, annual patient throughput, treatment of major tumor types, and clinical outcomes, the center has achieved a level comparable to that of leading domestic and international institutions in the field.

The 7th China (Gansu) Traditional Chinese Medicine Industry Expo is about to open in Longxi. To further amplify the brand impact of heavy ion therapy as a "national heavy instrument" and highlight Gansu's distinctive strengths in nuclear medicine, and in alignment with the province's integrated development strategy for biomedicine and nuclear medicine, Gansu Wuwei Cancer Hospital held a promotion conference on the high‑quality integrated development of heavy ion and nuclear medicine technologies and the green access medical model in Dingxi on September 2. The hospital will also feature a dedicated heavy ion exhibition at the 7th TCM Industry Expo. By integrating cutting‑edge heavy ion radiotherapy, targeted radionuclide therapy, and the rich advantages of traditional Chinese medicine resources in Gansu, the hospital aims to build a platform for promoting advanced cancer technologies, facilitate the distribution of high‑quality medical resources to the grassroots level, and support the

Debuting in the Capital! China's Heavy Ion Technology Goes Global. The Gansu Province Wuwei Tumor Hospital showcased domestic heavy ion technology in Beijing, highlighting breakthroughs and international achievements in precise tumor diagnosis and treatment, thereby contributing to "Healthy China" and the development of the Belt and Road Initiative.

Experts from the medical and health sectors of multiple countries visited the Wuwei Heavy Ion Center for exchanges and learning. As a benchmark for the clinical effectiveness of domestically produced heavy ion therapy, the center has attracted global experts to conduct inspections, share "Chinese experiences," and promote international medical cooperation and technological progress.

To promote the advancement and development of ion radiotherapy in China and to strengthen the exchange and sharing of clinical and radiophysical research experience, the "International Training Course on China's Carbon‑Ion Therapy System (Third Session)", hosted by Gansu Wuwei Cancer Hospital, is scheduled to be held from September 16 to September 20, 2026, in Wuwei.

In July 2026, cutting-edge achievements in China's heavy ion therapy sparked widespread discussion at the BMIT-GRN International Academic Symposium. Wuwei Cancer Hospital showcased its first independently developed heavy ion system and AI-enabled innovative projects, covering over a hundred types of tumors with efficacy surpassing international standards, thereby promoting deep integration of industry, academia, and research as well as enhanced international collaboration.

Leading Experts Convene in Wuwei to Chart New Course for Precision Radiotherapy in Lung Cancer

Gansu Province Wuwei Tumor Hospital has achieved a breakthrough in heavy ion fusion nuclear medicine therapy for tumors, hosting the nation's first and second heavy ion systems. It has launched alpha/beta radionuclide-targeted therapies to overcome challenges such as liver and pancreatic cancers, led the formulation of national diagnostic and treatment guidelines, and is guiding China's nuclear medicine sector toward global leadership.